Advances in Therapeutic Applications of Extracellular Vesicles

References

• Buzas EI. The roles of extracellular vesicles in the immune system. Nat Rev Immunol. 2022;22:1–15. doi:10.1038/s41577-022-00763-8
   PubMedGoogle Scholar
• Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009;19(2):43–51. doi:10.1016/j.tcb.2008.11.003
   PubMed Web of Science ®Google Scholar
• Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262(19):9412–9420. doi:10.1016/S0021-9258(18)48095-7
   PubMed Web of Science ®Google Scholar
• Johnstone RM. Revisiting the road to the discovery of exosomes. Blood Cells Mol Dis. 2005;34(3):214–219. doi:10.1016/j.bcmd.2005.03.002
   PubMed Web of Science ®Google Scholar
• Kay HM, Birss AJ, Smalley JW. Glycylprolyl dipeptidase activity of Bacteroides gingivalis W50 and the avirulent variant W50/BEI. FEMS Microbiol Lett. 1989;48(1):93–96. doi:10.1016/0378-1097(89)90153-5
   PubMedGoogle Scholar
• Obermayer G, Afonyushkin T, Göderle L, et al. Natural IgM antibodies inhibit microvesicle-driven coagulation and thrombosis. Blood. 2021;137(10):1406–1415. doi:10.1182/blood.2020007155
   PubMed Web of Science ®Google Scholar
• Lindenbergh MFS, Stoorvogel W. Antigen presentation by extracellular vesicles from professional antigen-presenting cells. Annu Rev Immunol. 2018;36:435–459. doi:10.1146/annurev-immunol-041015-055700
   PubMed Web of Science ®Google Scholar
• Couch Y, Buzàs EI, Di Vizio D, et al. A brief history of nearly EV-erything - the rise and rise of extracellular vesicles. J Extracell Vesicles. 2021;10(14):e12144. doi:10.1002/jev2.12144
   PubMed Web of Science ®Google Scholar
• Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. doi:10.1080/20013078.2018.1535750
   PubMed Web of Science ®Google Scholar
• O’Brien K, Breyne K, Ughetto S, Laurent LC, Breakefield XO. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol. 2020;21(10):585–606. doi:10.1038/s41580-020-0251-y
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Liao Z, Liu H, Ma L, et al. Engineering extracellular vesicles restore the impaired cellular uptake and attenuate intervertebral disc degeneration. ACS Nano. 2021;15(9):14709–14724. doi:10.1021/acsnano.1c04514
   PubMed Web of Science ®Google Scholar
• Yuana Y, Sturk A, Nieuwland R. Extracellular vesicles in physiological and pathological conditions. Blood Rev. 2013;27(1):31–39. doi:10.1016/j.blre.2012.12.002
   PubMed Web of Science ®Google Scholar
• Lai RC, Tan SS, Yeo RW, et al. MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA. J Extracell Vesicles. 2016;5:29828. doi:10.3402/jev.v5.29828
   PubMed Web of Science ®Google Scholar
• Valcz G, Buzás EI, Kittel Á, et al. En bloc release of MVB-like small extracellular vesicle clusters by colorectal carcinoma cells. J Extracell Vesicles. 2019;8(1):1596668. doi:10.1080/20013078.2019.1596668
   PubMed Web of Science ®Google Scholar
• van Niel G, Carter DRF, Clayton A, Lambert DW, Raposo G, Vader P. Challenges and directions in studying cell-cell communication by extracellular vesicles. Nat Rev Mol Cell Biol. 2022;23(5):369–382. doi:10.1038/s41580-022-00460-3
   PubMed Web of Science ®Google Scholar
• Oliveira GP, Zigon E, Rogers G, et al. Detection of extracellular vesicle RNA using molecular beacons. iScience. 2020;23(1):100782. doi:10.1016/j.isci.2019.100782
   PubMed Web of Science ®Google Scholar
• Skotland T, Hessvik NP, Sandvig K, Llorente A. Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. J Lipid Res. 2019;60(1):9–18. doi:10.1194/jlr.R084343
   PubMed Web of Science ®Google Scholar
• Laulagnier K, Motta C, Hamdi S, et al. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem J. 2004;380(Pt 1):161–171. doi:10.1042/bj20031594
   PubMed Web of Science ®Google Scholar
• Veerman RE, Teeuwen L, Czarnewski P, et al. Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin. J Extracell Vesicles. 2021;10(9):e12128. doi:10.1002/jev2.12128
   PubMed Web of Science ®Google Scholar
• Wen SW, Lima LG, Lobb RJ, et al. Breast cancer-derived exosomes reflect the cell-of-origin phenotype. Proteomics. 2019;19(8):e1800180. doi:10.1002/pmic.201800180
   PubMed Web of Science ®Google Scholar
• Ferguson SW, Nguyen J. Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity. J Control Release. 2016;228:179–190. doi:10.1016/j.jconrel.2016.02.037
   PubMed Web of Science ®Google Scholar
• van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–228. doi:10.1038/nrm.2017.125
   PubMed Web of Science ®Google Scholar
• Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19–30; sup pp 1–13. doi:10.1038/ncb2000
   Web of Science ®Google Scholar
• Mathieu M, Martin-Jaular L, Lavieu G, Théry C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21(1):9–17. doi:10.1038/s41556-018-0250-9
   PubMed Web of Science ®Google Scholar
• Larios J, Mercier V, Roux A, Gruenberg J. ALIX- and ESCRT-III-dependent sorting of tetraspanins to exosomes. J Cell Biol. 2020;219(3):154.
   Web of Science ®Google Scholar
• Wei D, Zhan W, Gao Y, et al. RAB31 marks and controls an ESCRT-independent exosome pathway. Cell Res. 2021;31(2):157–177. doi:10.1038/s41422-020-00409-1
   PubMed Web of Science ®Google Scholar
• Yang L, Peng X, Li Y, et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol Cancer. 2019;18(1):78. doi:10.1186/s12943-019-0990-6
   PubMed Web of Science ®Google Scholar
• Yu Z, Shi M, Stewart T, et al. Reduced oligodendrocyte exosome secretion in multiple system atrophy involves FasL dysfunction. Brain. 2020;143(6):1780–1797. doi:10.1093/brain/awaa110
   PubMedGoogle Scholar
• Agliardi C, Meloni M, Guerini FR, et al. Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson’s disease. Neurobiol Dis. 2021;148:105185. doi:10.1016/j.nbd.2020.105185
   PubMed Web of Science ®Google Scholar
• Clancy JW, Zhang Y, Sheehan C, D’Souza-Schorey C. An ARF6-Exportin-5 axis delivers pre-miRNA cargo to tumour microvesicles. Nat Cell Biol. 2019;21(7):856–866. doi:10.1038/s41556-019-0345-y
   PubMed Web of Science ®Google Scholar
• Wang T, Gilkes DM, Takano N, et al. Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proc Natl Acad Sci U S A. 2014;111(31):E3234–42. doi:10.1073/pnas.1410041111
   PubMed Web of Science ®Google Scholar
• Ashrafizaveh S, Ashrafizadeh M, Zarrabi A, et al. Long non-coding RNAs in the doxorubicin resistance of cancer cells. Cancer Lett. 2021;508:104–114. doi:10.1016/j.canlet.2021.03.018
   PubMed Web of Science ®Google Scholar
• Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. doi:10.3402/jev.v4.27066
   PubMed Web of Science ®Google Scholar
• Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3:24641. doi:10.3402/jev.v3.24641
   PubMedGoogle Scholar
• Costa Verdera H, Gitz-Francois JJ, Schiffelers RM, Vader P. Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis. J Control Release. 2017;266:100–108. doi:10.1016/j.jconrel.2017.09.019
   PubMed Web of Science ®Google Scholar
• Pitt JM, Kroemer G, Zitvogel L. Extracellular vesicles: masters of intercellular communication and potential clinical interventions. J Clin Invest. 2016;126(4):1139–1143. doi:10.1172/jci87316
   PubMed Web of Science ®Google Scholar
• Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol. 2021;16(7):748–759. doi:10.1038/s41565-021-00931-2
   PubMed Web of Science ®Google Scholar
• Najafi F, Kelaye SK, Kazemi B, et al. The role of miRNA-424 and miR-631 in various cancers: focusing on drug resistance and sensitivity. Pathol Res Pract. 2022;239:154130. doi:10.1016/j.prp.2022.154130
   PubMed Web of Science ®Google Scholar
• Hu Y, Rao SS, Wang ZX, et al. Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function. Theranostics. 2018;8(1):169–184. doi:10.7150/thno.21234
   PubMed Web of Science ®Google Scholar
• Yan C, Chen J, Wang C, et al. Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis. Drug Deliv. 2022;29(1):214–228. doi:10.1080/10717544.2021.2023699
   PubMed Web of Science ®Google Scholar
• Sung BH, von Lersner A, Guerrero J, et al. A live cell reporter of exosome secretion and uptake reveals pathfinding behavior of migrating cells. Nat Commun. 2020;11(1):2092. doi:10.1038/s41467-020-15747-2
   PubMed Web of Science ®Google Scholar
• Zhou X, Xie F, Wang L, et al. The function and clinical application of extracellular vesicles in innate immune regulation. Cell Mol Immunol. 2020;17(4):323–334. doi:10.1038/s41423-020-0391-1
   PubMed Web of Science ®Google Scholar
• Stenqvist AC, Nagaeva O, Baranov V, Mincheva-Nilsson L. Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus. J Immunol. 2013;191(11):5515–5523. doi:10.4049/jimmunol.1301885
   PubMed Web of Science ®Google Scholar
• Dumont TMF, Mouillet JF, Bayer A, et al. The expression level of C19MC miRNAs in early pregnancy and in response to viral infection. Placenta. 2017;53:23–29. doi:10.1016/j.placenta.2017.03.011
   PubMed Web of Science ®Google Scholar
• Tkach M, Kowal J, Zucchetti AE, et al. Qualitative differences in T-cell activation by dendritic cell-derived extracellular vesicle subtypes. EMBO j. 2017;36(20):3012–3028. doi:10.15252/embj.201696003
   PubMed Web of Science ®Google Scholar
• Lu Z, Zuo B, Jing R, et al. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models. J Hepatol. 2017;67(4):739–748. doi:10.1016/j.jhep.2017.05.019
   PubMed Web of Science ®Google Scholar
• Sato Y, Yaguchi M, Okuno Y, et al. Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection. Cell Commun Signal. 2022;20(1):95. doi:10.1186/s12964-022-00902-7
   PubMed Web of Science ®Google Scholar
• Zeng Z, Li Y, Pan Y, et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun. 2018;9(1):5395. doi:10.1038/s41467-018-07810-w
   PubMed Web of Science ®Google Scholar
• Mas-Bargues C, Borrás C, Alique M. The contribution of extracellular vesicles from senescent endothelial and vascular smooth muscle cells to vascular calcification. Front Cardiovasc Med. 2022;9:854726. doi:10.3389/fcvm.2022.854726
   PubMed Web of Science ®Google Scholar
• Liu X, Wang C, Meng H, Liao S, Zhang J, Guan Y, Tian H and Peng J. (2022). Research Progress on Exosomes in Osteonecrosis of the Femoral Head. Orthopaedic Surgery, 14(9), 1951–1957. 10.1111/os.13393
   PubMed Web of Science ®Google Scholar
• Buendía P, Montes de Oca A, Madueño JA, et al. Endothelial microparticles mediate inflammation-induced vascular calcification. FASEB j. 2015;29(1):173–181. doi:10.1096/fj.14-249706
   PubMed Web of Science ®Google Scholar
• Deb A, Gupta S, Mazumder PB. Exosomes: a new horizon in modern medicine. Life Sci. 2021;264:118623. doi:10.1016/j.lfs.2020.118623
   PubMed Web of Science ®Google Scholar
• Latifkar A, Hur YH, Sanchez JC, Cerione RA, Antonyak MA. New insights into extracellular vesicle biogenesis and function. J Cell Sci. 2019;132(13). doi:10.1242/jcs.222406
   PubMed Web of Science ®Google Scholar
• Knox MC, Ni J, Bece A, et al. A clinician’s guide to cancer-derived exosomes: immune interactions and therapeutic implications. Front Immunol. 2020;11:1612. doi:10.3389/fimmu.2020.01612
   PubMed Web of Science ®Google Scholar
• Kok VC, Yu CC. Cancer-derived exosomes: their role in cancer biology and biomarker development. Int J Nanomedicine. 2020;15:8019–8036. doi:10.2147/ijn.S272378
   PubMed Web of Science ®Google Scholar
• Song YH, Warncke C, Choi SJ, et al. Breast cancer-derived extracellular vesicles stimulate myofibroblast differentiation and pro-angiogenic behavior of adipose stem cells. Matrix Biol. 2017;60-61:190–205. doi:10.1016/j.matbio.2016.11.008
   PubMed Web of Science ®Google Scholar
• Feng Q, Zhang C, Lum D, et al. A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis. Nat Commun. 2017;8:14450. doi:10.1038/ncomms14450
   PubMed Web of Science ®Google Scholar
• Chen S, Crabill GA, Pritchard TS, et al. Mechanisms regulating PD-L1 expression on tumor and immune cells. J Immunother Cancer. 2019;7(1):305. doi:10.1186/s40425-019-0770-2
   PubMed Web of Science ®Google Scholar
• Yin Z, Yu M, Ma T, et al. Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1. J Immunother Cancer. 2021;9(1):e001698. doi:10.1136/jitc-2020-001698
   PubMed Web of Science ®Google Scholar
• Dou D, Ren X, Han M, et al. Cancer-associated fibroblasts-derived exosomes suppress immune cell function in breast cancer via the miR-92/PD-L1 pathway. Front Immunol. 2020;11:2026. doi:10.3389/fimmu.2020.02026
   PubMed Web of Science ®Google Scholar
• Pritchard A, Tousif S, Wang Y, et al. Lung tumor cell-derived exosomes promote M2 macrophage polarization. Cells. 2020;9(5):1303. doi:10.3390/cells9051303
   PubMed Web of Science ®Google Scholar
• Yeh YY, Ozer HG, Lehman AM, et al. Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling. Blood. 2015;125(21):3297–3305. doi:10.1182/blood-2014-12-618470
   PubMed Web of Science ®Google Scholar
• Qazi KR, Torregrosa Paredes P, Dahlberg B, Grunewald J, Eklund A, Gabrielsson S. Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis. Thorax. 2010;65(11):1016–1024. doi:10.1136/thx.2009.132027
   PubMed Web of Science ®Google Scholar
• Bai X, Li J, Li L, et al. Extracellular vesicles from adipose tissue-derived stem cells affect notch-miR148a-3p axis to regulate polarization of macrophages and alleviate sepsis in mice. Front Immunol. 2020;11:1391. doi:10.3389/fimmu.2020.01391
   PubMed Web of Science ®Google Scholar
• Crenshaw BJ, Gu L, Sims B, Matthews QL. Exosome biogenesis and biological function in response to viral infections. Open Virol J. 2018;12:134–148. doi:10.2174/1874357901812010134
   PubMedGoogle Scholar
• Ebrahimkhani S, Beadnall HN, Wang C, et al. Serum exosome microRNAs predict multiple sclerosis disease activity after fingolimod treatment. Mol Neurobiol. 2020;57(2):1245–1258. doi:10.1007/s12035-019-01792-6
   PubMed Web of Science ®Google Scholar
• Tian Y, Wang T, Bu H, Shao G, Zhang W and Zhang L. (2022). Role of Exosomal miR ‐223 in Chronic Skeletal Muscle Inflammation. Orthopaedic Surgery, 14(4), 644–651. 10.1111/os.13232
   PubMed Web of Science ®Google Scholar
• Rani S, Ryan AE, Griffin MD, Ritter T. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol Ther. 2015;23(5):812–823. doi:10.1038/mt.2015.44
   PubMed Web of Science ®Google Scholar
• Crapnell K, Blaesius R, Hastings A, Lennon DP, Caplan AI, Bruder SP. Growth, differentiation capacity, and function of mesenchymal stem cells expanded in serum-free medium developed via combinatorial screening. Exp Cell Res. 2013;319(10):1409–1418. doi:10.1016/j.yexcr.2013.04.004
   PubMed Web of Science ®Google Scholar
• Volarevic V, Markovic BS, Gazdic M, et al. Ethical and safety issues of stem cell-based therapy. Int J Med Sci. 2018;15(1):36–45. doi:10.7150/ijms.21666
   PubMed Web of Science ®Google Scholar
• Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008;132(4):661–680. doi:10.1016/j.cell.2008.02.008
   PubMed Web of Science ®Google Scholar
• De Trizio E, Brennan CS. The business of human embryonic stem cell research and an international analysis of relevant laws. J Biolaw Bus. 2004;7(4):14–22.
   PubMedGoogle Scholar
• Breitbach M, Bostani T, Roell W, et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 2007;110(4):1362–1369. doi:10.1182/blood-2006-12-063412
   PubMed Web of Science ®Google Scholar
• Yoshihara M, Hayashizaki Y, Murakawa Y. Genomic instability of iPSCs: challenges towards their clinical applications. Stem Cell Rev Rep. 2017;13(1):7–16. doi:10.1007/s12015-016-9680-6
   PubMed Web of Science ®Google Scholar
• Tsiapalis D, O’Driscoll L. Mesenchymal stem cell derived extracellular vesicles for tissue engineering and regenerative medicine applications. Cells. 2020;9(4):991. doi:10.3390/cells9040991
   PubMed Web of Science ®Google Scholar
• van Balkom BWM, Gremmels H, Giebel B, Lim SK. Proteomic signature of mesenchymal stromal cell-derived small extracellular vesicles. Proteomics. 2019;19(1–2):e1800163. doi:10.1002/pmic.201800163
   PubMed Web of Science ®Google Scholar
• Zhao M, Liu S, Wang C, et al. Mesenchymal stem cell-derived extracellular vesicles attenuate mitochondrial damage and inflammation by stabilizing mitochondrial DNA. ACS Nano. 2021;15(1):1519–1538. doi:10.1021/acsnano.0c08947
   PubMed Web of Science ®Google Scholar
• Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells. 2019;8(12):1605. doi:10.3390/cells8121605
   PubMed Web of Science ®Google Scholar
• Xia Y, Hu G, Chen Y, et al. Embryonic stem cell derived small extracellular vesicles modulate regulatory T cells to protect against ischemic stroke. ACS Nano. 2021;15(4):7370–7385. doi:10.1021/acsnano.1c00672
   PubMed Web of Science ®Google Scholar
• Mathew B, Ravindran S, Liu X, et al. Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion. Biomaterials. 2019;197:146–160. doi:10.1016/j.biomaterials.2019.01.016
   PubMed Web of Science ®Google Scholar
• Xia C, Zeng Z, Fang B, et al. Mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration via anti-oxidant and anti-inflammatory effects. Free Radic Biol Med. 2019;143:1–15. doi:10.1016/j.freeradbiomed.2019.07.026
   PubMed Web of Science ®Google Scholar
• He L, He T, Xing J, et al. Bone marrow mesenchymal stem cell-derived exosomes protect cartilage damage and relieve knee osteoarthritis pain in a rat model of osteoarthritis. Stem Cell Res Ther. 2020;11(1):276. doi:10.1186/s13287-020-01781-w
   PubMed Web of Science ®Google Scholar
• Wang R, Xu B. TGF-β1-modified MSC-derived exosomal miR-135b attenuates cartilage injury via promoting M2 synovial macrophage polarization by targeting MAPK6. Cell Tissue Res. 2021;384(1):113–127. doi:10.1007/s00441-020-03319-1
   PubMed Web of Science ®Google Scholar
• Yan B, Zhang Y, Liang C, et al. Stem cell-derived exosomes prevent pyroptosis and repair ischemic muscle injury through a novel exosome/circHIPK3/ FOXO3a pathway. Theranostics. 2020;10(15):6728–6742. doi:10.7150/thno.42259
   PubMed Web of Science ®Google Scholar
• Ibrahim AG, Cheng K, Marbán E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep. 2014;2(5):606–619. doi:10.1016/j.stemcr.2014.04.006
   PubMed Web of Science ®Google Scholar
• Lan B, Zeng S, Grützmann R, Pilarsky C. The role of exosomes in pancreatic cancer. Int J Mol Sci. 2019;20(18):4332. doi:10.3390/ijms20184332
   PubMed Web of Science ®Google Scholar
• Li W, Mu D, Tian F, et al. Exosomes derived from Rab27a‑overexpressing tumor cells elicit efficient induction of antitumor immunity. Mol Med Rep. 2013;8(6):1876–1882. doi:10.3892/mmr.2013.1738
   PubMed Web of Science ®Google Scholar
• Jorfi S, Ansa-Addo EA, Kholia S, et al. Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo. Sci Rep. 2015;5:13006. doi:10.1038/srep13006
   PubMed Web of Science ®Google Scholar
• Siklos M, BenAissa M, Thatcher GR. Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors. Acta Pharm Sin B. 2015;5(6):506–519. doi:10.1016/j.apsb.2015.08.001
   PubMed Web of Science ®Google Scholar
• Datta A, Kim H, Lal M, et al. Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells. Cancer Lett. 2017;408:73–81. doi:10.1016/j.canlet.2017.08.020
   PubMed Web of Science ®Google Scholar
• Shilo A, Ben Hur V, Denichenko P, et al. Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development. Rna. 2014;20(4):505–515. doi:10.1261/rna.042259.113
   PubMed Web of Science ®Google Scholar
• Tamai K, Tanaka N, Nakano T, et al. Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein. Biochem Biophys Res Commun. 2010;399(3):384–390. doi:10.1016/j.bbrc.2010.07.083
   PubMed Web of Science ®Google Scholar
• Baranger K, van Gijsel-Bonnello M, Stephan D, et al. Long-term pantethine treatment counteracts pathologic gene dysregulation and decreases alzheimer’s disease pathogenesis in a transgenic mouse model. Neurotherapeutics. 2019;16(4):1237–1254. doi:10.1007/s13311-019-00754-z
   PubMed Web of Science ®Google Scholar
• Ranganathan S, Jackson RL, Harmony JA. Effect of pantethine on the biosynthesis of cholesterol in human skin fibroblasts. Atherosclerosis. 1982;44(3):261–273. doi:10.1016/0021-9150(82)90002-8
   PubMed Web of Science ®Google Scholar
• Penet MF, Abou-Hamdan M, Coltel N, et al. Protection against cerebral malaria by the low-molecular-weight thiol pantethine. Proc Natl Acad Sci U S A. 2008;105(4):1321–1326. doi:10.1073/pnas.0706867105
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Takahashi Y, Nishikawa M, et al. Accelerated growth of B16BL6 tumor in mice through efficient uptake of their own exosomes by B16BL6 cells. Cancer Sci. 2017;108(9):1803–1810. doi:10.1111/cas.13310
   PubMed Web of Science ®Google Scholar
• Barger JF, Rahman MA, Jackson D, Acunzo M, Nana-Sinkam SP. Extracellular miRNAs as biomarkers in cancer. Food Chem Toxicol. 2016;98(Pt A):66–72. doi:10.1016/j.fct.2016.06.010
   PubMedGoogle Scholar
• Bastos N, Ruivo CF, da Silva S, Melo SA. Exosomes in cancer: use them or target them? Semin Cell Dev Biol. 2018;78:13–21. doi:10.1016/j.semcdb.2017.08.009
   PubMed Web of Science ®Google Scholar
• Luo Z, Hu X, Wu C, et al. Plasma exosomes generated by ischaemic preconditioning are cardioprotective in a rat heart failure model. Br J Anaesth. 2022;130:29–38. doi:10.1016/j.bja.2022.08.040
   PubMed Web of Science ®Google Scholar
• Wei FS, Rao MW, Huang YL, Chen SB, Wu YQ, Yang L. miR-182-5p delivered by plasma exosomes promotes sevoflurane-induced neuroinflammation and cognitive dysfunction in aged rats with postoperative cognitive dysfunction by targeting brain-derived neurotrophic factor and activating NF-κB pathway. Neurotox Res. 2022;40:1902–1912. doi:10.1007/s12640-022-00597-1
   PubMed Web of Science ®Google Scholar
• Wang L, Yang L, Zhuang T, Shi X. Tumor-derived exosomal miR-29b reduces angiogenesis in pancreatic cancer by silencing ROBO1 and SRGAP2. J Immunol Res. 2022;2022:4769385. doi:10.1155/2022/4769385
   PubMed Web of Science ®Google Scholar
• Fitzner D, Schnaars M, van Rossum D, et al. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci. 2011;124(Pt 3):447–458. doi:10.1242/jcs.074088
   PubMed Web of Science ®Google Scholar
• Feng D, Zhao WL, Ye YY, et al. Cellular internalization of exosomes occurs through phagocytosis. Traffic. 2010;11(5):675–687. doi:10.1111/j.1600-0854.2010.01041.x
   PubMed Web of Science ®Google Scholar
• Tian T, Zhu YL, Zhou YY, et al. Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J Biol Chem. 2014;289(32):22258–22267. doi:10.1074/jbc.M114.588046
   PubMed Web of Science ®Google Scholar
• Escrevente C, Keller S, Altevogt P, Costa J. Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer. 2011;11:108. doi:10.1186/1471-2407-11-108
   PubMed Web of Science ®Google Scholar
• Lima LG, Chammas R, Monteiro RQ, Moreira ME, Barcinski MA. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett. 2009;283(2):168–175. doi:10.1016/j.canlet.2009.03.041
   PubMed Web of Science ®Google Scholar
• Christianson HC, Svensson KJ, van Kuppevelt TH, Li JP, Belting M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc Natl Acad Sci U S A. 2013;110(43):17380–17385. doi:10.1073/pnas.1304266110
   PubMed Web of Science ®Google Scholar
• Xu R, Rai A, Chen M, Suwakulsiri W, Greening DW, Simpson RJ. Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol. 2018;15(10):617–638. doi:10.1038/s41571-018-0036-9
   PubMed Web of Science ®Google Scholar
• Naito Y, Yoshioka Y, Yamamoto Y, Ochiya T. How cancer cells dictate their microenvironment: present roles of extracellular vesicles. Cell Mol Life Sci. 2017;74(4):697–713. doi:10.1007/s00018-016-2346-3
   PubMed Web of Science ®Google Scholar
• Marleau AM, Chen CS, Joyce JA, Tullis RH. Exosome removal as a therapeutic adjuvant in cancer. J Transl Med. 2012;10:134. doi:10.1186/1479-5876-10-134
   PubMed Web of Science ®Google Scholar
• Ciravolo V, Huber V, Ghedini GC, et al. Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol. 2012;227(2):658–667. doi:10.1002/jcp.22773
   PubMed Web of Science ®Google Scholar
• Li S, Yi M, Dong B, Tan X, Luo S, Wu K. The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction. Int J Cancer. 2021;148(11):2640–2651. doi:10.1002/ijc.33386
   PubMed Web of Science ®Google Scholar
• Sala M, Ros M, Saltel F. A complex and evolutive character: two face aspects of ECM in tumor progression. Front Oncol. 2020;10:1620. doi:10.3389/fonc.2020.01620
   PubMed Web of Science ®Google Scholar
• Li W, Liu JB, Hou LK, et al. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring. Mol Cancer. 2022;21(1):25. doi:10.1186/s12943-022-01505-z
   PubMed Web of Science ®Google Scholar
• Zhou B, Xu K, Zheng X, et al. Application of exosomes as liquid biopsy in clinical diagnosis. Signal Transduct Target Ther. 2020;5(1):144. doi:10.1038/s41392-020-00258-9
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hu YW, Zheng L, Wang Q. Characteristics and roles of exosomes in cardiovascular disease. DNA Cell Biol. 2017;36(3):202–211. doi:10.1089/dna.2016.3496
   PubMed Web of Science ®Google Scholar
• Fitts CA, Ji N, Li Y, Tan C. Exploiting exosomes in cancer liquid biopsies and drug delivery. Adv Healthc Mater. 2019;8(6):e1801268. doi:10.1002/adhm.201801268
   PubMed Web of Science ®Google Scholar
• Ohmichi T, Mitsuhashi M, Tatebe H, Kasai T, Ali El-Agnaf OM, Tokuda T. Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson’s and related diseases. Parkinsonism Relat Disord. 2019;61:82–87. doi:10.1016/j.parkreldis.2018.11.021
   PubMed Web of Science ®Google Scholar
• Kitamura Y, Kojima M, Kurosawa T, et al. Proteomic profiling of exosomal proteins for blood-based biomarkers in parkinson’s disease. Neuroscience. 2018;392:121–128. doi:10.1016/j.neuroscience.2018.09.017
   PubMed Web of Science ®Google Scholar
• Pasetto L, Callegaro S, Corbelli A, et al. Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis. Mol Neurodegener. 2021;16(1):52. doi:10.1186/s13024-021-00470-3
   PubMed Web of Science ®Google Scholar
• Song Y, Wang M, Tong H, et al. Plasma exosomes from endometrial cancer patients contain LGALS3BP to promote endometrial cancer progression. Oncogene. 2021;40(3):633–646. doi:10.1038/s41388-020-01555-x
   PubMed Web of Science ®Google Scholar
• Wang L, Liu J, Xu B, Liu YL, Liu Z. Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure. Kaohsiung J Med Sci. 2018;34(11):626–633. doi:10.1016/j.kjms.2018.05.008
   PubMed Web of Science ®Google Scholar
• Wang L, Lv Y, Li G, Xiao J. MicroRNAs in heart and circulation during physical exercise. J Sport Health Sci. 2018;7(4):433–441. doi:10.1016/j.jshs.2018.09.008
   PubMed Web of Science ®Google Scholar
• Wu T, Chen Y, Du Y, et al. Circulating exosomal miR-92b-5p is a promising diagnostic biomarker of heart failure with reduced ejection fraction patients hospitalized for acute heart failure. J Thorac Dis. 2018;10(11):6211–6220. doi:10.21037/jtd.2018.10.52
   PubMed Web of Science ®Google Scholar
• Xu JY, Chen GH, Yang YJ. Exosomes: a rising star in falling hearts. Front Physiol. 2017;8:494. doi:10.3389/fphys.2017.00494
   PubMed Web of Science ®Google Scholar
• Kuwabara Y, Ono K, Horie T, et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet. 2011;4(4):446–454. doi:10.1161/circgenetics.110.958975
   PubMedGoogle Scholar
• Maegdefessel L, Azuma J, Tsao PS. MicroRNA-29b regulation of abdominal aortic aneurysm development. Trends Cardiovasc Med. 2014;24(1):1–6. doi:10.1016/j.tcm.2013.05.002
   PubMed Web of Science ®Google Scholar
• Bang C, Batkai S, Dangwal S, et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest. 2014;124(5):2136–2146. doi:10.1172/jci70577
   PubMed Web of Science ®Google Scholar
• Fang X, Stroud MJ, Ouyang K, et al. Adipocyte-specific loss of PPARγ attenuates cardiac hypertrophy. JCI Insight. 2016;1(16):e89908. doi:10.1172/jci.insight.89908
   PubMed Web of Science ®Google Scholar
• Han ZL, Wang HQ, Zhang TS, He YX, Zhou H. Up-regulation of exosomal miR-106a may play a significant role in abdominal aortic aneurysm by inducing vascular smooth muscle cell apoptosis and targeting TIMP-2, an inhibitor of metallopeptidases that suppresses extracellular matrix degradation. Eur Rev Med Pharmacol Sci. 2020;24(15):8087–8095. doi:10.26355/eurrev_202008_22493
   PubMed Web of Science ®Google Scholar
• Maegdefessel L, Spin JM, Raaz U, et al. miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development. Nat Commun. 2014;5:5214. doi:10.1038/ncomms6214
   PubMed Web of Science ®Google Scholar
• Ling H, Guo Z, Du S, et al. Serum exosomal miR-122-5p is a new biomarker for both acute coronary syndrome and underlying coronary artery stenosis. Biomarkers. 2020;25(7):539–547. doi:10.1080/1354750x.2020.1803963
   PubMed Web of Science ®Google Scholar
• Xue S, Liu D, Zhu W, et al. Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p are novel biomarkers for diagnosis of acute myocardial infarction. Front Physiol. 2019;10:123. doi:10.3389/fphys.2019.00123
   PubMed Web of Science ®Google Scholar
• Ghosh S, Bhowmik S, Majumdar S, et al. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein. Int J Cancer. 2020;147(10):2934–2947. doi:10.1002/ijc.33111
   PubMed Web of Science ®Google Scholar
• Gonzalez-Villasana V, Rashed MH, Gonzalez-Cantú Y, et al. Presence of circulating miR-145, miR-155, and miR-382 in exosomes isolated from serum of breast cancer patients and healthy donors. Dis Markers. 2019;2019:6852917. doi:10.1155/2019/6852917
   PubMed Web of Science ®Google Scholar
• Li D, Wang J, Ma LJ, et al. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer. Eur Rev Med Pharmacol Sci. 2020;24(13):7303–7309. doi:10.26355/eurrev_202007_21889
   PubMed Web of Science ®Google Scholar
• Zhao P, Cheng J, Li B, et al. Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas. Cell Biol Toxicol. 2021;37(4):633–651. doi:10.1007/s10565-020-09570-0
   PubMed Web of Science ®Google Scholar
• Xiong Y, Tang Y, Fan F, et al. Exosomal hsa-miR-21-5p derived from growth hormone-secreting pituitary adenoma promotes abnormal bone formation in acromegaly. Transl Res. 2020;215:1–16. doi:10.1016/j.trsl.2019.07.013
   PubMed Web of Science ®Google Scholar
• Yu T, Wang Y, Fan Y, et al. CircRNAs in cancer metabolism: a review. J Hematol Oncol. 2019;12(1):90. doi:10.1186/s13045-019-0776-8
   PubMed Web of Science ®Google Scholar
• Lin L, Cai GX, Zhai XM, et al. Plasma-derived extracellular vesicles circular RNAs serve as biomarkers for breast cancer diagnosis. Front Oncol. 2021;11:752651. doi:10.3389/fonc.2021.752651
   PubMed Web of Science ®Google Scholar
• Wang M, Wang Y, Ye F, et al. Exosome encapsulated ncRNAs in the development of HCC: potential circulatory biomarkers and clinical therapeutic targets. Am J Cancer Res. 2021;11(8):3794–3812.
   PubMed Web of Science ®Google Scholar
• Chen W, Quan Y, Fan S, et al. Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression. Cancer Lett. 2020;475:119–128. doi:10.1016/j.canlet.2020.01.022
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang S, Wang H, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer. 2019;18(1):20. doi:10.1186/s12943-018-0935-5
   PubMed Web of Science ®Google Scholar
• Li T, Zhou T, Wu J, et al. Plasma exosome-derived circGAPVD1 as a potential diagnostic marker for colorectal cancer. Transl Oncol. 2023;31:101652. doi:10.1016/j.tranon.2023.101652
   PubMed Web of Science ®Google Scholar
• Lin LY, Yang L, Zeng Q, et al. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer. Mol Cancer. 2018;17(1):84. doi:10.1186/s12943-018-0834-9
   PubMed Web of Science ®Google Scholar
• Ye Q, Li L, Shao Z, et al. Association between lncRNAs in plasma exosomes and diabetic retinopathy. Front Endocrinol (Lausanne). 2022;13:987488. doi:10.3389/fendo.2022.987488
   PubMed Web of Science ®Google Scholar
• Kang JY, Mun D, Kim H, Yun N, Joung B. Serum exosomal long noncoding RNAs as a diagnostic biomarker for atrial fibrillation. Heart Rhythm. 2022;19(9):1450–1458. doi:10.1016/j.hrthm.2022.05.033
   PubMed Web of Science ®Google Scholar
• Bajo-Santos C, Brokāne A, Zayakin P, et al. Plasma and urinary extracellular vesicles as a source of RNA biomarkers for prostate cancer in liquid biopsies. Front Mol Biosci. 2023;10:980433. doi:10.3389/fmolb.2023.980433
   PubMed Web of Science ®Google Scholar
• Zhu L, Li J, Gong Y, et al. Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis. Mol Cancer. 2019;18(1):74. doi:10.1186/s12943-019-1000-8
   PubMed Web of Science ®Google Scholar
• Zheng B, Song X, Wang L, et al. Plasma exosomal tRNA-derived fragments as diagnostic biomarkers in non-small cell lung cancer. Front Oncol. 2022;12:1037523. doi:10.3389/fonc.2022.1037523
   PubMed Web of Science ®Google Scholar
• Chen S, Zhang X, Meng K, et al. Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis. Front Immunol. 2023;14:1077645. doi:10.3389/fimmu.2023.1077645
   PubMed Web of Science ®Google Scholar
• Hu L, Zhang T, Ma H, et al. Discovering the secret of diseases by incorporated tear exosomes analysis via rapid-isolation system: iTEARS. ACS Nano. 2022;16:11720–11732. doi:10.1021/acsnano.2c02531
   PubMed Web of Science ®Google Scholar
• Zhao H, Pan S, Natalia A, et al. A hydrogel-based mechanical metamaterial for the interferometric profiling of extracellular vesicles in patient samples. Nat Biomed Eng. 2022;7:135–148. doi:10.1038/s41551-022-00954-7
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341–345. doi:10.1038/nbt.1807
   PubMed Web of Science ®Google Scholar
• Cooper JM, Wiklander PB, Nordin JZ, et al. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord. 2014;29(12):1476–1485. doi:10.1002/mds.25978
   PubMed Web of Science ®Google Scholar
• Liu Y, Li D, Liu Z, et al. Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse. Sci Rep. 2015;5:17543. doi:10.1038/srep17543
   PubMed Web of Science ®Google Scholar
• Möller A, Lobb RJ. The evolving translational potential of small extracellular vesicles in cancer. Nat Rev Cancer. 2020;20(12):697–709. doi:10.1038/s41568-020-00299-w
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Yeri A, Cheah PS, et al. Small RNA sequencing across diverse biofluids identifies optimal methods for exRNA isolation. Cell. 2019;177(2):446–462.e16. doi:10.1016/j.cell.2019.03.024
   PubMed Web of Science ®Google Scholar
• György B, Hung ME, Breakefield XO, Leonard JN. Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu Rev Pharmacol Toxicol. 2015;55:439–464. doi:10.1146/annurev-pharmtox-010814-124630
   PubMed Web of Science ®Google Scholar
• Murphy DE, de Jong OG, Brouwer M, et al. Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking. Exp Mol Med. 2019;51(3):1–12. doi:10.1038/s12276-019-0223-5
   PubMedGoogle Scholar
• Hoppstädter J, Dembek A, Linnenberger R, et al. Toll-like receptor 2 release by macrophages: an anti-inflammatory program induced by glucocorticoids and lipopolysaccharide. Front Immunol. 2019;10:1634. doi:10.3389/fimmu.2019.01634
   PubMed Web of Science ®Google Scholar
• Mittelbrunn M, Gutiérrez-Vázquez C, Villarroya-Beltri C, et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun. 2011;2:282. doi:10.1038/ncomms1285
   PubMed Web of Science ®Google Scholar
• Yu M, Gai C, Li Z, et al. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells. Cancer Sci. 2019;110(10):3173–3182. doi:10.1111/cas.14181
   PubMed Web of Science ®Google Scholar
• Li S, Wu Y, Ding F, et al. Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer. Nanoscale. 2020;12(19):10854–10862. doi:10.1039/d0nr00523a
   PubMed Web of Science ®Google Scholar
• Zhu ZH, Jia F, Ahmed W, et al. Neural stem cell-derived exosome as a nano-sized carrier for BDNF delivery to a rat model of ischemic stroke. Neural Regen Res. 2023;18(2):404–409. doi:10.4103/1673-5374.346466
   PubMed Web of Science ®Google Scholar
• Sheller-Miller S, Radnaa E, Yoo JK, et al. Exosomal delivery of NF-κB inhibitor delays LPS-induced preterm birth and modulates fetal immune cell profile in mouse models. Sci Adv. 2021;7(4):54.
   Web of Science ®Google Scholar
• Wang X, Zhang H, Yang H, et al. Cell-derived exosomes as promising carriers for drug delivery and targeted therapy. Curr Cancer Drug Targets. 2018;18(4):347–354. doi:10.2174/1568009617666170710120311
   PubMed Web of Science ®Google Scholar
• Tan A, Rajadas J, Seifalian AM. Exosomes as nano-theranostic delivery platforms for gene therapy. Adv Drug Deliv Rev. 2013;65(3):357–367. doi:10.1016/j.addr.2012.06.014
   PubMed Web of Science ®Google Scholar
• Yang Z, Shi J, Xie J, et al. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat Biomed Eng. 2020;4(1):69–83. doi:10.1038/s41551-019-0485-1
   PubMed Web of Science ®Google Scholar
• Gebeyehu A, Kommineni N, Meckes DG, Sachdeva MS. Role of exosomes for delivery of chemotherapeutic drugs. Crit Rev Ther Drug Carrier Syst. 2021;38(5):53–97. doi:10.1615/CritRevTherDrugCarrierSyst.2021036301
   PubMed Web of Science ®Google Scholar
• Sun J, Shen H, Shao L, et al. HIF-1α overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis. Stem Cell Res Ther. 2020;11(1):373. doi:10.1186/s13287-020-01881-7
   PubMed Web of Science ®Google Scholar
• Zheng Y, Song A, Zhou Y, et al. Identification of extracellular vesicles-transported miRNAs in Erlotinib-resistant head and neck squamous cell carcinoma. J Cell Commun Signal. 2020;14(4):389–402. doi:10.1007/s12079-020-00546-7
   PubMed Web of Science ®Google Scholar
• McCann J, Sosa-Miranda CD, Guo H, et al. Contaminating transfection complexes can masquerade as small extracellular vesicles and impair their delivery of RNA. J Extracell Vesicles. 2022;11(10):e12220. doi:10.1002/jev2.12220
   PubMed Web of Science ®Google Scholar
• Lamichhane TN, Raiker RS, Jay SM. Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery. Mol Pharm. 2015;12(10):3650–3657. doi:10.1021/acs.molpharmaceut.5b00364
   PubMed Web of Science ®Google Scholar
• Gomari H, Forouzandeh Moghadam M, Soleimani M, Ghavami M, Khodashenas S. Targeted delivery of doxorubicin to HER2 positive tumor models. Int J Nanomedicine. 2019;14:5679–5690. doi:10.2147/ijn.S210731
   PubMed Web of Science ®Google Scholar
• Liang G, Kan S, Zhu Y, Feng S, Feng W, Gao S. Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells. Int J Nanomedicine. 2018;13:585–599. doi:10.2147/ijn.S154458
   PubMed Web of Science ®Google Scholar
• Jeyaram A, Lamichhane TN, Wang S, et al. Enhanced loading of functional miRNA cargo via pH gradient modification of extracellular vesicles. Mol Ther. 2020;28(3):975–985. doi:10.1016/j.ymthe.2019.12.007
   PubMed Web of Science ®Google Scholar
• Familtseva A, Jeremic N, Tyagi SC. Exosomes: cell-created drug delivery systems. Mol Cell Biochem. 2019;459(1–2):1–6. doi:10.1007/s11010-019-03545-4
   PubMed Web of Science ®Google Scholar
• Radnaa E, Richardson LS, Sheller-Miller S, et al. Extracellular vesicle mediated feto-maternal HMGB1 signaling induces preterm birth. Lab Chip. 2021;21(10):1956–1973. doi:10.1039/d0lc01323d
   PubMed Web of Science ®Google Scholar
• Fu W, Lei C, Liu S, et al. CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity. Nat Commun. 2019;10(1):4355. doi:10.1038/s41467-019-12321-3
   PubMed Web of Science ®Google Scholar
• Xu Z, Zeng S, Gong Z, Yan Y. Exosome-based immunotherapy: a promising approach for cancer treatment. Mol Cancer. 2020;19(1):160. doi:10.1186/s12943-020-01278-3
   PubMed Web of Science ®Google Scholar
• Armstrong JP, Holme MN, Stevens MM. Re-engineering extracellular vesicles as smart nanoscale therapeutics. ACS Nano. 2017;11(1):69–83. doi:10.1021/acsnano.6b07607
   PubMed Web of Science ®Google Scholar
• Ma S, Song L, Bai Y, et al. Improved intracellular delivery of exosomes by surface modification with fluorinated peptide dendrimers for promoting angiogenesis and migration of HUVECs. RSC Adv. 2023;13(17):11269–11277. doi:10.1039/d3ra00300k
   PubMed Web of Science ®Google Scholar
• Rana S, Yue S, Stadel D, Zöller M. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int J Biochem Cell Biol. 2012;44(9):1574–1584. doi:10.1016/j.biocel.2012.06.018
   PubMed Web of Science ®Google Scholar
• Mentkowski KI, Lang JK. Exosomes engineered to express a cardiomyocyte binding peptide demonstrate improved cardiac retention in vivo. Sci Rep. 2019;9(1):10041. doi:10.1038/s41598-019-46407-1
   PubMedGoogle Scholar
• Liang G, Zhu Y, Ali DJ, et al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnology. 2020;18(1):10. doi:10.1186/s12951-019-0563-2
   PubMed Web of Science ®Google Scholar
• Cheng Q, Shi X, Han M, Smbatyan G, Lenz HJ, Zhang Y. Reprogramming exosomes as nanoscale controllers of cellular immunity. J Am Chem Soc. 2018;140(48):16413–16417. doi:10.1021/jacs.8b10047
   PubMed Web of Science ®Google Scholar
• Kim HY, Kim TJ, Kang L, et al. Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of ischemic stroke. Biomaterials. 2020;243:119942. doi:10.1016/j.biomaterials.2020.119942
   PubMed Web of Science ®Google Scholar
• Kamerkar S, Leng C, Burenkova O, et al. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity. Sci Adv. 2022;8(7):eabj7002. doi:10.1126/sciadv.abj7002
   PubMed Web of Science ®Google Scholar
• Kooijmans SAA, Fliervoet LAL, van der Meel R, et al. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J Control Release. 2016;224:77–85. doi:10.1016/j.jconrel.2016.01.009
   PubMed Web of Science ®Google Scholar
• Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498–503. doi:10.1038/nature22341
   PubMed Web of Science ®Google Scholar
• Wei Z, Chen Z, Zhao Y, et al. Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment. Biomaterials. 2021;275:121000. doi:10.1016/j.biomaterials.2021.121000
   PubMed Web of Science ®Google Scholar
• Belhadj Z, He B, Deng H, et al. A combined “eat me/don’t eat me” strategy based on extracellular vesicles for anticancer nanomedicine. J Extracell Vesicles. 2020;9(1):1806444. doi:10.1080/20013078.2020.1806444
   PubMed Web of Science ®Google Scholar
• Gómez-Cid L, López-Donaire ML, Velasco D, et al. Cardiac extracellular matrix hydrogel enriched with polyethylene glycol presents improved gelation time and increased on-target site retention of extracellular vesicles. Int J Mol Sci. 2021;22(17):9226. doi:10.3390/ijms22179226
   PubMed Web of Science ®Google Scholar
• Liang X, Niu Z, Galli V, et al. Extracellular vesicles engineered to bind albumin demonstrate extended circulation time and lymph node accumulation in mouse models. J Extracell Vesicles. 2022;11(7):e12248. doi:10.1002/jev2.12248
   PubMed Web of Science ®Google Scholar
• Wiklander OP, Nordin JZ, O’Loughlin A, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4:26316. doi:10.3402/jev.v4.26316
   PubMed Web of Science ®Google Scholar
• Iancu EM, Kandalaft LE. Challenges and advantages of cell therapy manufacturing under good manufacturing practices within the hospital setting. Curr Opin Biotechnol. 2020;65:233–241. doi:10.1016/j.copbio.2020.05.005
   PubMed Web of Science ®Google Scholar
• Rohde E, Pachler K, Gimona M. Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing. Cytotherapy. 2019;21(6):581–592. doi:10.1016/j.jcyt.2018.12.006
   PubMed Web of Science ®Google Scholar
• LeBleu VS, Kalluri R. Exosomes as a multicomponent biomarker platform in cancer. Trends Cancer. 2020;6(9):767–774. doi:10.1016/j.trecan.2020.03.007
   PubMed Web of Science ®Google Scholar
• Islam MK, Syed P, Lehtinen L, et al. A nanoparticle-based approach for the detection of extracellular vesicles. Sci Rep. 2019;9(1):10038. doi:10.1038/s41598-019-46395-2
   PubMedGoogle Scholar
• Baranyai T, Herczeg K, Onódi Z, et al. Isolation of exosomes from blood plasma: qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods. PLoS One. 2015;10(12):e0145686. doi:10.1371/journal.pone.0145686
   PubMed Web of Science ®Google Scholar
• Stranska R, Gysbrechts L, Wouters J, et al. Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma. J Transl Med. 2018;16(1):1. doi:10.1186/s12967-017-1374-6
   PubMedGoogle Scholar
• Kitka D, Mihály J, Fraikin JL, Beke-Somfai T, Varga Z. Detection and phenotyping of extracellular vesicles by size exclusion chromatography coupled with on-line fluorescence detection. Sci Rep. 2019;9(1):19868. doi:10.1038/s41598-019-56375-1
   PubMedGoogle Scholar
• Van Deun J, Jo A, Li H, et al. Integrated dual-mode chromatography to enrich extracellular vesicles from plasma. Adv Biosyst. 2020;4(12):e1900310. doi:10.1002/adbi.201900310
   PubMed Web of Science ®Google Scholar
• Zhang X, Borg EGF, Liaci AM, Vos HR, Stoorvogel W. A novel three step protocol to isolate extracellular vesicles from plasma or cell culture medium with both high yield and purity. J Extracell Vesicles. 2020;9(1):1791450. doi:10.1080/20013078.2020.1791450
   PubMed Web of Science ®Google Scholar
• Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int. 2018;2018:8545347. doi:10.1155/2018/8545347
   PubMed Web of Science ®Google Scholar
• Bordas M, Genard G, Ohl S, et al. Optimized protocol for isolation of small extracellular vesicles from human and murine lymphoid tissues. Int J Mol Sci. 2020;21(15):5586. doi:10.3390/ijms21155586
   PubMed Web of Science ®Google Scholar
• Sidhom K, Obi PO, Saleem A. A review of exosomal isolation methods: is size exclusion chromatography the best option? Int J Mol Sci. 2020;21(18):6466. doi:10.3390/ijms21186466
   PubMed Web of Science ®Google Scholar
• Nordin JZ, Lee Y, Vader P, et al. Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. Nanomedicine. 2015;11(4):879–883. doi:10.1016/j.nano.2015.01.003
   PubMed Web of Science ®Google Scholar
• Soltani F, Parhiz H, Mokhtarzadeh A, Ramezani M. Synthetic and biological vesicular nano-carriers designed for gene delivery. Curr Pharm Des. 2015;21(42):6214–6235. doi:10.2174/1381612821666151027153410
   PubMed Web of Science ®Google Scholar
• Witwer KW, Wolfram J. Extracellular vesicles versus synthetic nanoparticles for drug delivery. Nat Rev Mater. 2021;6(2):103–106. doi:10.1038/s41578-020-00277-6
   PubMed Web of Science ®Google Scholar
• Severic M, Ma G, Pereira SGT, Ruiz A, Cheung CCL, Al-Jamal WT. Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo. J Control Release. 2021;330:101–110. doi:10.1016/j.jconrel.2020.12.017
   PubMed Web of Science ®Google Scholar
• Zhao Q, Hai B, Zhang X, Xu J, Koehler B, Liu F. Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer. Nanomedicine. 2020;24:102146. doi:10.1016/j.nano.2019.102146
   PubMed Web of Science ®Google Scholar
• Li YJ, Wu JY, Wang JM, Hu XB, Xiang DX. Emerging strategies for labeling and tracking of extracellular vesicles. J Control Release. 2020;328:141–159. doi:10.1016/j.jconrel.2020.08.056
   PubMed Web of Science ®Google Scholar
• Thippabhotla S, Zhong C, He M. 3D cell culture stimulates the secretion of in vivo like extracellular vesicles. Sci Rep. 2019;9(1):13012. doi:10.1038/s41598-019-49671-3
   PubMedGoogle Scholar
• de Abreu RC, Fernandes H, da Costa Martins PA, Sahoo S, Emanueli C, Ferreira L. Native and bioengineered extracellular vesicles for cardiovascular therapeutics. Nat Rev Cardiol. 2020;17(11):685–697. doi:10.1038/s41569-020-0389-5
   PubMed Web of Science ®Google Scholar
• Ikeda G, Santoso MR, Tada Y, et al. Mitochondria-rich extracellular vesicles from autologous stem cell-derived cardiomyocytes restore energetics of ischemic myocardium. J Am Coll Cardiol. 2021;77(8):1073–1088. doi:10.1016/j.jacc.2020.12.060
   PubMed Web of Science ®Google Scholar
• Villa A, Garofalo M, Crescenti D, et al. Transplantation of autologous extracellular vesicles for cancer-specific targeting. Theranostics. 2021;11(5):2034–2047. doi:10.7150/thno.51344
   PubMed Web of Science ®Google Scholar
• Lener T, Gimona M, Aigner L, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015;4:30087. doi:10.3402/jev.v4.30087
   PubMed Web of Science ®Google Scholar
• Escudier B, Dorval T, Chaput N, et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med. 2005;3(1):10. doi:10.1186/1479-5876-3-10
   PubMed Web of Science ®Google Scholar
• Kumar DN, Chaudhuri A, Aqil F, et al. Exosomes as emerging drug delivery and diagnostic modality for breast cancer: recent advances in isolation and application. Cancers. 2022;14(6):1435. doi:10.3390/cancers14061435
   PubMed Web of Science ®Google Scholar
• Huda MN, Nafiujjaman M, Deaguero IG, et al. Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: progress in clinical and preclinical applications. ACS Biomater Sci Eng. 2021;7(6):2106–2149. doi:10.1021/acsbiomaterials.1c00217
   PubMed Web of Science ®Google Scholar